Awarded

Ustekinumab 130 mg vial

Name: Ustekinumab 130 mg vial
Creator: SERVICIO NAVARRO DE SALUD-OSASUNBIDEA
Published: 2026-09-24
License: https://ted.europa.eu/en/simap/legal-notice

Track this recordFree account — get alerted when a contract here runs out.

Buyer: SERVICIO NAVARRO DE SALUD-OSASUNBIDEA
Winners: BIOCON BIOLOGICS SPAIN, S.L.
Contract value: €268,260
Bids received: 7
Published: 24 Sept 2026
Awarded: 23 Sept 2025
Contract start: 23 Sept 2025
Contract end: 24 Sept 2026estimated
Sector: Medical equipment and pharmaceuticals
Region: Navarra
Source: Original notice on TED (662616-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
LOTE ÚNICO: Material fungible para mapeo y ablación cardiaca de doble energía	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	MEDTRONIC IBERICA SA	€426,934	24 Sept 2026
Ustekinumab 45 mg jeringa/pluma y Ustekinumab 90 mg jeringa/pluma	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	BIOCON BIOLOGICS SPAIN, S.L.	€3,376,200	24 Sept 2026
TECVAYLI 90 MG/ML VIAL	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026
TALVEY (40 MG/ML) 40 MG VIAL	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026
SIMPONI 100 MG 1 PLUMA PRECARGADA	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026
SIMPONI 50 MG 1 PLUMA PRECARGADA	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026